Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 28-Jun-2021
No. of pages: 127
Inquire Before Buying

Single Nucleotide Polymorphism (SNP) Genotyping is the measurement of genetic variations of single nucleotide polymorphisms (SNPs) between members of a species. It is a form of genotyping, which is the measurement of more general genetic variation. SNP genotyping is not only the genetic markers present in most, but also the most promising markers. SNP genotyping as the most potential for development of molecular markers, it cans achieve large-scale highly automated, thus it is more suited to a huge number of detection and analysis, has been widely used in biology, agriculture, medicine, biological evolution and other fields.

SNP genotyping is the simplest form of DNA variation among individuals. These simple changes can be of transition or transversion type and they occur throughout the genome at a frequency of about one in 1,000 bp. In the whole SNP genotyping industry, only a few companies can provide SNP genotyping platform while SNP genotyping service provider are located widely in the world.

SNP genotyping has various genotyping methods, such as TaqMan probe method, SNaPshot method, .MassArray method, .Illumina BeadXpress, HRM method and so on. Each method has its own characteristics. SNP genotyping will adopt an appropriate method according their customers' specific demand or wanted results.

Illumina, Affymetrix and Applied Biosystems are industry leaders. They can provide SNP genotyping platform, reagent and service to their clients. Besides, all of them have authorized companies around the word to use their platform to offer genotyping service to some countries. In fact, in the platform field, the industry is still highly monopolized for the time being.

We tend to believe that this industry still has a bright future, considering the current gene research. There is also no doubt that there are will be more and more companies to provide innovative SNP genotyping related products and service to customers in the next few years, promoting the industry to develop healthily.

Market Analysis and Insights: Global Single Nucleotide Polymorphism (SNP) Genotyping Market

The global Single Nucleotide Polymorphism (SNP) Genotyping market size is projected to reach US$ 53310 million by 2027, from US$ 13960 million in 2020, at a CAGR of 21.1% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Single Nucleotide Polymorphism (SNP) Genotyping market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Single Nucleotide Polymorphism (SNP) Genotyping market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Single Nucleotide Polymorphism (SNP) Genotyping market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Single Nucleotide Polymorphism (SNP) Genotyping market.

Global Single Nucleotide Polymorphism (SNP) Genotyping Scope and Market Size

Single Nucleotide Polymorphism (SNP) Genotyping market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Single Nucleotide Polymorphism (SNP) Genotyping market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Transversion

- Transition

Segment by Application

- Diagnostics

- Animal

- Plant

- Research

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Illumina

- Affymetrix

- Applied Biosystems

- Agilent Technologies

- Beckman Coulter

- Roche

- Qiagen

- Luminex Corporation

- Enzo Life Sciences

- Bio-rad

- Sequenom

- Ocimum Biosolutions

- GE Healthcare

- GenScript

- Douglas Scientific

- BGI

- Beijing Sunbiotech

- HuaGene Biotech

- Generay Biotech

- Benegene

- Shanghai Biochip

- GENESKY

- HD Biosciences

Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Transversion
1.2.3 Transition
1.3 Market by Application
1.3.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diagnostics
1.3.3 Animal
1.3.4 Plant
1.3.5 Research
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Perspective (2016-2027)
2.2 Single Nucleotide Polymorphism (SNP) Genotyping Growth Trends by Regions
2.2.1 Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Single Nucleotide Polymorphism (SNP) Genotyping Historic Market Share by Regions (2016-2021)
2.2.3 Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Regions (2022-2027)
2.3 Single Nucleotide Polymorphism (SNP) Genotyping Industry Dynamic
2.3.1 Single Nucleotide Polymorphism (SNP) Genotyping Market Trends
2.3.2 Single Nucleotide Polymorphism (SNP) Genotyping Market Drivers
2.3.3 Single Nucleotide Polymorphism (SNP) Genotyping Market Challenges
2.3.4 Single Nucleotide Polymorphism (SNP) Genotyping Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Single Nucleotide Polymorphism (SNP) Genotyping Players by Revenue
3.1.1 Global Top Single Nucleotide Polymorphism (SNP) Genotyping Players by Revenue (2016-2021)
3.1.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Players (2016-2021)
3.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Single Nucleotide Polymorphism (SNP) Genotyping Revenue
3.4 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Concentration Ratio
3.4.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Single Nucleotide Polymorphism (SNP) Genotyping Revenue in 2020
3.5 Single Nucleotide Polymorphism (SNP) Genotyping Key Players Head office and Area Served
3.6 Key Players Single Nucleotide Polymorphism (SNP) Genotyping Product Solution and Service
3.7 Date of Enter into Single Nucleotide Polymorphism (SNP) Genotyping Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Single Nucleotide Polymorphism (SNP) Genotyping Breakdown Data by Type
4.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Historic Market Size by Type (2016-2021)
4.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Type (2022-2027)
5 Single Nucleotide Polymorphism (SNP) Genotyping Breakdown Data by Application
5.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Historic Market Size by Application (2016-2021)
5.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2016-2027)
6.2 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type
6.2.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2016-2021)
6.2.2 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2022-2027)
6.2.3 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2016-2027)
6.3 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application
6.3.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2016-2021)
6.3.2 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2022-2027)
6.3.3 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2016-2027)
6.4 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country
6.4.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2016-2021)
6.4.2 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2016-2027)
7.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type
7.2.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2016-2021)
7.2.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2022-2027)
7.2.3 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2016-2027)
7.3 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application
7.3.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2016-2021)
7.3.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2022-2027)
7.3.3 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2016-2027)
7.4 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country
7.4.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2016-2021)
7.4.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2016-2027)
8.2 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type
8.2.1 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2016-2027)
8.3 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application
8.3.1 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2016-2027)
8.4 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region
8.4.1 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2016-2027)
9.2 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type
9.2.1 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2016-2021)
9.2.2 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2022-2027)
9.2.3 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2016-2027)
9.3 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application
9.3.1 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2016-2021)
9.3.2 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2022-2027)
9.3.3 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2016-2027)
9.4 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country
9.4.1 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2016-2021)
9.4.2 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2016-2027)
10.2 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type
10.2.1 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2016-2027)
10.3 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application
10.3.1 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2016-2027)
10.4 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country
10.4.1 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.1.4 Illumina Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.1.5 Illumina Recent Development
11.2 Affymetrix
11.2.1 Affymetrix Company Details
11.2.2 Affymetrix Business Overview
11.2.3 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.2.4 Affymetrix Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.2.5 Affymetrix Recent Development
11.3 Applied Biosystems
11.3.1 Applied Biosystems Company Details
11.3.2 Applied Biosystems Business Overview
11.3.3 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.3.4 Applied Biosystems Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.3.5 Applied Biosystems Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.4.4 Agilent Technologies Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.4.5 Agilent Technologies Recent Development
11.5 Beckman Coulter
11.5.1 Beckman Coulter Company Details
11.5.2 Beckman Coulter Business Overview
11.5.3 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.5.4 Beckman Coulter Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.5.5 Beckman Coulter Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.6.4 Roche Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.6.5 Roche Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Details
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.7.4 Qiagen Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.7.5 Qiagen Recent Development
11.8 Luminex Corporation
11.8.1 Luminex Corporation Company Details
11.8.2 Luminex Corporation Business Overview
11.8.3 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.8.4 Luminex Corporation Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.8.5 Luminex Corporation Recent Development
11.9 Enzo Life Sciences
11.9.1 Enzo Life Sciences Company Details
11.9.2 Enzo Life Sciences Business Overview
11.9.3 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.9.4 Enzo Life Sciences Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.9.5 Enzo Life Sciences Recent Development
11.10 Bio-rad
11.10.1 Bio-rad Company Details
11.10.2 Bio-rad Business Overview
11.10.3 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.10.4 Bio-rad Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.10.5 Bio-rad Recent Development
11.11 Sequenom
11.11.1 Sequenom Company Details
11.11.2 Sequenom Business Overview
11.11.3 Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.11.4 Sequenom Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.11.5 Sequenom Recent Development
11.12 Ocimum Biosolutions
11.12.1 Ocimum Biosolutions Company Details
11.12.2 Ocimum Biosolutions Business Overview
11.12.3 Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.12.4 Ocimum Biosolutions Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.12.5 Ocimum Biosolutions Recent Development
11.13 GE Healthcare
11.13.1 GE Healthcare Company Details
11.13.2 GE Healthcare Business Overview
11.13.3 GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.13.4 GE Healthcare Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.13.5 GE Healthcare Recent Development
11.14 GenScript
11.14.1 GenScript Company Details
11.14.2 GenScript Business Overview
11.14.3 GenScript Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.14.4 GenScript Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.14.5 GenScript Recent Development
11.15 Douglas Scientific
11.15.1 Douglas Scientific Company Details
11.15.2 Douglas Scientific Business Overview
11.15.3 Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.15.4 Douglas Scientific Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.15.5 Douglas Scientific Recent Development
11.16 BGI
11.16.1 BGI Company Details
11.16.2 BGI Business Overview
11.16.3 BGI Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.16.4 BGI Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.16.5 BGI Recent Development
11.17 Beijing Sunbiotech
11.17.1 Beijing Sunbiotech Company Details
11.17.2 Beijing Sunbiotech Business Overview
11.17.3 Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.17.4 Beijing Sunbiotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.17.5 Beijing Sunbiotech Recent Development
11.18 HuaGene Biotech
11.18.1 HuaGene Biotech Company Details
11.18.2 HuaGene Biotech Business Overview
11.18.3 HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.18.4 HuaGene Biotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.18.5 HuaGene Biotech Recent Development
11.18 Generay Biotech
.1 Generay Biotech Company Details
.2 Generay Biotech Business Overview
.3 Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Introduction
.4 Generay Biotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
.5 Generay Biotech Recent Development
11.20 Benegene
11.20.1 Benegene Company Details
11.20.2 Benegene Business Overview
11.20.3 Benegene Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.20.4 Benegene Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.20.5 Benegene Recent Development
11.21 Shanghai Biochip
11.21.1 Shanghai Biochip Company Details
11.21.2 Shanghai Biochip Business Overview
11.21.3 Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.21.4 Shanghai Biochip Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.21.5 Shanghai Biochip Recent Development
11.22 GENESKY
11.22.1 GENESKY Company Details
11.22.2 GENESKY Business Overview
11.22.3 GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.22.4 GENESKY Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.22.5 GENESKY Recent Development
11.23 HD Biosciences
11.23.1 HD Biosciences Company Details
11.23.2 HD Biosciences Business Overview
11.23.3 HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.23.4 HD Biosciences Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021)
11.23.5 HD Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Transversion
Table 3. Key Players of Transition
Table 4. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Regions (2016-2021)
Table 8. Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Regions (2022-2027)
Table 10. Single Nucleotide Polymorphism (SNP) Genotyping Market Trends
Table 11. Single Nucleotide Polymorphism (SNP) Genotyping Market Drivers
Table 12. Single Nucleotide Polymorphism (SNP) Genotyping Market Challenges
Table 13. Single Nucleotide Polymorphism (SNP) Genotyping Market Restraints
Table 14. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Players (2016-2021)
Table 16. Global Top Single Nucleotide Polymorphism (SNP) Genotyping Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Single Nucleotide Polymorphism (SNP) Genotyping as of 2020)
Table 17. Ranking of Global Top Single Nucleotide Polymorphism (SNP) Genotyping Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Single Nucleotide Polymorphism (SNP) Genotyping Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Single Nucleotide Polymorphism (SNP) Genotyping Product Solution and Service
Table 21. Date of Enter into Single Nucleotide Polymorphism (SNP) Genotyping Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2016-2021)
Table 25. Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application (2016-2021)
Table 29. Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2022-2027) & (US$ Million)
Table 61. Illumina Company Details
Table 62. Illumina Business Overview
Table 63. Illumina Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 64. Illumina Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 65. Illumina Recent Development
Table 66. Affymetrix Company Details
Table 67. Affymetrix Business Overview
Table 68. Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 69. Affymetrix Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 70. Affymetrix Recent Development
Table 71. Applied Biosystems Company Details
Table 72. Applied Biosystems Business Overview
Table 73. Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 74. Applied Biosystems Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 75. Applied Biosystems Recent Development
Table 76. Agilent Technologies Company Details
Table 77. Agilent Technologies Business Overview
Table 78. Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 79. Agilent Technologies Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 80. Agilent Technologies Recent Development
Table 81. Beckman Coulter Company Details
Table 82. Beckman Coulter Business Overview
Table 83. Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 84. Beckman Coulter Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 85. Beckman Coulter Recent Development
Table 86. Roche Company Details
Table 87. Roche Business Overview
Table 88. Roche Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 89. Roche Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 90. Roche Recent Development
Table 91. Qiagen Company Details
Table 92. Qiagen Business Overview
Table 93. Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 94. Qiagen Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 95. Qiagen Recent Development
Table 96. Luminex Corporation Company Details
Table 97. Luminex Corporation Business Overview
Table 98. Luminex Corporation Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 99. Luminex Corporation Recent Development
Table 100. Enzo Life Sciences Company Details
Table 101. Enzo Life Sciences Business Overview
Table 102. Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 103. Enzo Life Sciences Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 104. Enzo Life Sciences Recent Development
Table 105. Bio-rad Company Details
Table 106. Bio-rad Business Overview
Table 107. Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 108. Bio-rad Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 109. Bio-rad Recent Development
Table 110. Sequenom Company Details
Table 111. Sequenom Business Overview
Table 112. Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 113. Sequenom Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 114. Sequenom Recent Development
Table 115. Ocimum Biosolutions Company Details
Table 116. Ocimum Biosolutions Business Overview
Table 117. Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 118. Ocimum Biosolutions Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 119. Ocimum Biosolutions Recent Development
Table 120. GE Healthcare Company Details
Table 121. GE Healthcare Business Overview
Table 122. GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 123. GE Healthcare Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 124. GE Healthcare Recent Development
Table 125. GenScript Company Details
Table 126. GenScript Business Overview
Table 127. GenScript Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 128. GenScript Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 129. GenScript Recent Development
Table 130. Douglas Scientific Company Details
Table 131. Douglas Scientific Business Overview
Table 132. Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 133. Douglas Scientific Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 134. Douglas Scientific Recent Development
Table 135. BGI Company Details
Table 136. BGI Business Overview
Table 137. BGI Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 138. BGI Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 139. BGI Recent Development
Table 140. Beijing Sunbiotech Company Details
Table 141. Beijing Sunbiotech Business Overview
Table 142. Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 143. Beijing Sunbiotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 144. Beijing Sunbiotech Recent Development
Table 145. HuaGene Biotech Company Details
Table 146. HuaGene Biotech Business Overview
Table 147. HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 148. HuaGene Biotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 149. HuaGene Biotech Recent Development
Table 150. Generay Biotech Company Details
Table 151. Generay Biotech Business Overview
Table 152. Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 153. Generay Biotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2016-2021) & (US$ Million)
Table 154. Generay Biotech Recent Development
Table 155. Benegene Company Details
Table 156. Benegene Business Overview
Table 157. Benegene Single Nucleotide
  • Global Sanger Sequencing Service Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 149
    According to our LPI (LP Information) latest study, the global Sanger Sequencing Service market size was valued at US$ 209 million in 2023. With growing demand in downstream market, the Sanger Sequencing Service is forecast to a readjusted size of US$ 206.7 million by 2030 with a CAGR of -0.2% during review period. The research report highlights the growth potential of the global Sanger Sequencing Service market. Sanger Sequencing Service are expected to show stable growth in the future ......
  • Global Whole Exome Sequencing Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Whole Exome Sequencing market size was valued at US$ 289.6 million in 2023. With growing demand in downstream market, the Whole Exome Sequencing is forecast to a readjusted size of US$ 633.2 million by 2030 with a CAGR of 11.8% during review period. The research report highlights the growth potential of the global Whole Exome Sequencing market. Whole Exome Sequencing are expected to show stable growth in the future market. Ho......
  • Global Single Nucleotide Polymorphism (SNP) Genotyping Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 154
    According to our LPI (LP Information) latest study, the global Single Nucleotide Polymorphism (SNP) Genotyping market size was valued at US$ 16530 million in 2023. With growing demand in downstream market, the Single Nucleotide Polymorphism (SNP) Genotyping is forecast to a readjusted size of US$ 66080 million by 2030 with a CAGR of 21.9% during review period. The research report highlights the growth potential of the global Single Nucleotide Polymorphism (SNP) Genotyping market. Single ......
  • Global CRISPR and CRISPR-Associated (Cas) Genes Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125
    According to our LPI (LP Information) latest study, the global CRISPR and CRISPR-Associated (Cas) Genes market size was valued at US$ 1354.3 million in 2023. With growing demand in downstream market, the CRISPR and CRISPR-Associated (Cas) Genes is forecast to a readjusted size of US$ 10020 million by 2030 with a CAGR of 33.1% during review period. The research report highlights the growth potential of the global CRISPR and CRISPR-Associated (Cas) Genes market. CRISPR and CRISPR-Associate......
  • Global Polymerase Chain Reaction (Pcr) Products Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 120
    Market Overview of Global Polymerase Chain Reaction (Pcr) Products market: According to our latest research, the global Polymerase Chain Reaction (Pcr) Products market looks promising in the next 5 years. As of 2022, the global Polymerase Chain Reaction (Pcr) Products market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents......
  • Next Generation Sequencing - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 102
    This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Next Generation Sequencing, with both quanti......
  • Polymerase Chain Reaction (PCR) Products - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 124
    This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Polymerase Chain Reaction (PCR) Products, wi......
  • Global Genotyping Market Status and Outlook 2023-2028
    Published: 26-Dec-2023        Price: US 3160 Onwards        Pages: 128
    Genotyping is the technology that detects small genetic differences that can lead to major changes in phenotype, including both physical differences that make us unique and pathological changes underlying disease. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals wh......
  • Global Pyrosequencing Professional Survey Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 101
    Pyrosequencing is a method of DNA sequencing that detects light emitted from nucleotide bases.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital f......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs